Stay updated on BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page
- Check5 days agoChange DetectedRemoved the explicit study condition 'Multiple myeloma' and the related topics section linked to MedlinePlus Genetics. This changes how the page presents disease context and access to a genetics information resource.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page’s “related topics”/navigation area now includes additional medical resources, and the site’s UI builds/version label was updated from v3.5.2 to v3.5.3. This reflects a non-clinical site update rather than a change to the trial record itself.SummaryDifference0.2%

- Check20 days agoChange DetectedAdded Revision: v3.5.2. Removed Revision: v3.5.0.SummaryDifference0.1%

- Check27 days agoChange DetectedRemoved the 'Multiple Myeloma' condition label and the 'MedlinePlus Genetics' related topics from the study page.SummaryDifference0.2%

- Check41 days agoChange DetectedAdded related topics for the study: Multiple myeloma and MedlinePlus Genetics.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision: v3.5.0 added. The page no longer includes 'Multiple myeloma' or 'MedlinePlus Genetics' as related topics in the related topics section.SummaryDifference0.2%

Stay in the know with updates to BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCMA CAR T Cells ± Lenalidomide in Myeloma Clinical Trial page.